Dong, Yaa-HuiYaa-HuiDongCHIA-HSUIN CHANGJOU-WEI LINWEI-SHUN YANGWu, Li-ChiuLi-ChiuWuToh, SengweeSengweeToh2022-09-152022-09-1520221462-8902https://scholars.lib.ntu.edu.tw/handle/123456789/620551To examine the comparative effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors for select cardiovascular outcomes and to examine whether the relative risks varied across different patient subgroups in patients with type 2 diabetes.encardiovascular disease; chronic kidney disease; cohort study; glucagon-like peptide-1 receptor agonists (GLP-1RAs); haemorrhagic stroke; heart failure; ischaemic stroke; myocardial infarction; sodium glucose cotransporter-2 (SGLT2); stroke; type 2 diabetes[SDGs]SDG3journal article10.1111/dom.14741354915332-s2.0-85130522709WOS:000800059000001https://scholars.lib.ntu.edu.tw/handle/123456789/613237